Efficacy and safety of insulin glargine/lixisenatide fixed combination versus insulin glargine alone on top of metformin in type 2 diabetic patients

Registry ID

EUCTR2011-002090-36

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

sanofi-aventis Recherche et Développement

Start date

2012-02-07

Completion date

2012-12-17

Last update

2026-08-16

Conditions

• Type II Diabetes Mellitus

Summary

To compare insulin glargine/ lixisenatide fixed ratio combination versus insulin glargine on glycemic control over 24 weeks, as evaluated by HbA1c (glycosylated hemoglobin) reduction in type 2 diabetic patients treated with metformin

Locations

• , , Slovakia
• , , Germany
• , , Lithuania
• , , Czechia
• , , Hungary
• , , Denmark
• , , Sweden
• , , Poland

Related clinical trials

• The GRoceries Aimed at Increasing Nutrition Study
• A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
• cfMSC Therapy for Diabetes
• Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
• Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency
• Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study

View on source registry